250 related articles for article (PubMed ID: 16575003)
21. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
LaGrange CA; Lele SM; Strup SE
Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.
Rao Q; Liu B; Cheng L; Zhu Y; Shi QL; Wu B; Jiang SJ; Wang Y; Wang X; Yu B; Zhang RS; Ma HH; Lu ZF; Tu P; Wang JD; Zhou XJ
Am J Surg Pathol; 2012 Sep; 36(9):1327-38. PubMed ID: 22895266
[TBL] [Abstract][Full Text] [Related]
24. PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.
Onder AM; Teomete U; Argani P; Toledano S; Zilleruelo G; Rodriguez MM
Pediatr Nephrol; 2006 Oct; 21(10):1471-5. PubMed ID: 16807766
[TBL] [Abstract][Full Text] [Related]
25. MiT family translocation renal cell carcinoma.
Argani P
Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
[TBL] [Abstract][Full Text] [Related]
26. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients.
Sukov WR; Hodge JC; Lohse CM; Leibovich BC; Thompson RH; Pearce KE; Wiktor AE; Cheville JC
Am J Surg Pathol; 2012 May; 36(5):663-70. PubMed ID: 22498819
[TBL] [Abstract][Full Text] [Related]
27. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.
Meyer PN; Clark JI; Flanigan RC; Picken MM
Am J Clin Pathol; 2007 Jul; 128(1):70-9. PubMed ID: 17580272
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
Ishiguro M; Iwasaki H; Ohjimi Y; Kaneko Y
Oncol Rep; 2004 Jun; 11(6):1169-75. PubMed ID: 15138551
[TBL] [Abstract][Full Text] [Related]
29. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
[TBL] [Abstract][Full Text] [Related]
30. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X
Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774
[TBL] [Abstract][Full Text] [Related]
31. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
33. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
34. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.
Heimann P; El Housni H; Ogur G; Weterman MA; Petty EM; Vassart G
Cancer Res; 2001 May; 61(10):4130-5. PubMed ID: 11358836
[TBL] [Abstract][Full Text] [Related]
35. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
36. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
[TBL] [Abstract][Full Text] [Related]
37. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
Weterman MA; van Groningen JJ; Tertoolen L; van Kessel AG
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13808-13. PubMed ID: 11717438
[TBL] [Abstract][Full Text] [Related]
38. Translocation carcinoma of the kidney.
Paras FA; MacLennan GT
J Urol; 2008 May; 179(5):2007. PubMed ID: 18355851
[No Abstract] [Full Text] [Related]
39. Xp11 translocation renal cell carcinoma.
Ross H; Argani P
Pathology; 2010 Jun; 42(4):369-73. PubMed ID: 20438411
[TBL] [Abstract][Full Text] [Related]
40. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma.
Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH
AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]